9月,LeMaitre Vastore公司管理层出席了三次投资者会议。 LeMaitre Vascular management attends three investor conferences in September.
LeMaitre Vascular（纳斯达克股票代码：LMAT）管理层将参加 9 月的三场投资者会议，包括摩根士丹利第 22 届全球医疗保健年会和 Cantor Fitzgerald 的 2024 年全球医疗保健会议。 LeMaitre Vascular (NASDAQ: LMAT) management will attend three investor conferences in September, including Morgan Stanley's 22nd Annual Global Healthcare Conference and Cantor Fitzgerald's 2024 Global Healthcare Conference. 总裁戴维·罗伯茨将会做出演讲,而首席执行官乔治·W·莱梅特将在巴林顿研究公司的秋季投资会议上主持1×1会议. President David Roberts will present, while CEO George W. LeMaitre will host 1x1 meetings at Barrington Research's Fall Investment Conference. 莱梅特血管公司提供设备,植入物和服务,用于治疗外周血管疾病,影响全球超过2亿人. LeMaitre Vascular provides devices, implants, and services for peripheral vascular disease treatment, affecting over 200 million people worldwide.